Company Filing History:
2 out of 611 
1 out of 3,100 
1 out of 1 Years Active: 2021-2024
Title: Zhen Liang: Innovator in Plant Genomics
Introduction
Zhen Liang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of plant genomics, particularly through his innovative methods for genome modification. With a total of 2 patents, his work is paving the way for advancements in agricultural biotechnology.
Latest Patents
Zhen Liang's latest patents include a method for making site-directed modifications to plant genomes using non-inheritable materials. This invention provides a novel approach to conducting site-directed modifications by introducing a non-inheritable material into plant cells. The method utilizes a sequence-specific nuclease to cleave the target fragment, allowing for precise modifications without integrating exogenous genes into the plant. This innovation enhances genome function studies and improves biosafety in breeding practices.
Another significant patent involves the use of SUSD2 protein as a marker for identifying, selecting, or separating pancreatic internal secretion precursor cells and newborn pancreatic internal secretion cells. The research highlights the enrichment expression of the SUSD2 gene in these specific cell types, facilitating advancements in regenerative medicine and cell therapy.
Career Highlights
Zhen Liang has worked with esteemed institutions such as Peking University and the Chinese Academy of Sciences. His research has garnered attention for its potential applications in both agriculture and medicine, showcasing his versatility as an inventor.
Collaborations
Zhen Liang has collaborated with notable colleagues, including Caixia Gao and Yanpeng Wang. Their joint efforts have contributed to the advancement of research in plant genomics and cellular biology.
Conclusion
Zhen Liang's innovative work in plant genomics and cellular research exemplifies the impact of modern inventions on science and technology. His contributions are essential for future developments in biotechnology and regenerative medicine.